Fact CheckerSign in

NCT07264114Completed

Aquatic High-Intensity Interval Training for Parkinson's Disease

The Effect of Aquatic High-Intensity Interval Training on Balance, Physical Function, and Sarcopenia in Patients With Parkinson's Disease: A Randomized Controlled Trial Protocol

Source: ClinicalTrials.gov · Last updated 6 Jul 2026

Brief summary (registry, in English)

This randomized, single-center, parallel-group superiority trial will evaluate the effect of an 8-week aquatic High-Intensity Interval Training (HIIT) program on balance, physical function, and sarcopenia-related outcomes in individuals with Parkinson's disease (PD). The intervention aims to deliver Tabata-style aquatic HIIT (3 sessions/week) in a therapeutic pool to determine adherence and preliminary efficacy compared with standard care (no structured exercise program).

Status (registry)
Completed
Study type
Interventional
Enrollment
56 (actual)
First submitted
18 Nov 2025
Start date
10 Dec 2025
Primary completion date
10 Mar 2026
Lead sponsor
Pardis Specialized Wellness Institute
NCT number
NCT07264114

What you commit to

  • Study type: Interventional
  • Participants enrolled: 56
  • From 10 Dec 2025 to the primary completion date, 10 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cardiac instability (angina, decompensated congestive heart failure, severe arteriovenous stenosis, uncontrolled arrhythmias, etc.)
  • Active infection or acute medical illness

Other

  • Hemodynamic instability
  • Labile glycemic control
  • Inability to exercise (e.g. lower extremity amputation with no prosthesis)
  • Severe musculoskeletal pain at rest or with minimal activity
  • Inability to sit, stand or walk unassisted (walking device such as cane or walker allowed)
  • Shortness of breath at rest or with activities of daily living

Who the study is looking for

  • PD stages 2-3 based on Hoehn and Yahr classification system
  • Balance difficulty (BBS score \<45)
  • Reduced motor function
  • Sarcopenia (per EWGSOP2 criteria)
  • Age ≥ 55
  • Permission from their doctors to participate
  • Absence of a history of myocardial infarction within the past 3 months
  • Capacity to provide informed consent to participate in the study

Age in the registry: 55 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pardis specialized wellness institute
Coordinator of this site? Confirm its status
IsfahanIranUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.